天津医药 ›› 2015, Vol. 43 ›› Issue (6): 666-668.doi: 10.11958/j.issn.0253-9896.2015.06.024

• 药物临床观察 • 上一篇    下一篇

高原地区藏族人群中坎地沙坦治疗慢性收缩性心力衰竭疗效观察

郭娟, 于向东, 加永泽培, 徐绍鹏, 李斌#br# #br#   

  1. 西藏昌都地区人民医院内科

  • 收稿日期:2014-10-14 修回日期:2015-01-23 出版日期:2015-06-15 发布日期:2015-06-10
  • 通讯作者: 郭娟 E-mail:412409763@qq.com
  • 基金资助:
    西藏昌都地区重点科技项目 (昌地财农指[2010]114号)

Investigation on the treatment effect of chronic systolic heart failure with Candesartan in plateau Tibetan nationality

GUO Juan, YU Xiangdong, JIAYONG Zepei, XU Shaopeng, LI Bin#br# #br#   

  • Received:2014-10-14 Revised:2015-01-23 Published:2015-06-15 Online:2015-06-10

摘要: 目的 探讨坎地沙坦治疗慢性收缩性心力衰竭在高原地区藏族中的疗效。方法 将526例藏族慢性收缩性心衰患者随机分治疗组252例和对照组274例,2组均在治疗原发病的基础上,给予常规强心、利尿、扩血管类药物,对照组加用依那普利,治疗组加用坎地沙坦。治疗8周后,比较2组间的心功能改善程度、LVEF、LVEDD及血压有无统计学差异。 结果 治疗组的显效率(45.2%)、有效率(52.8%)、无效率(2.0%)与对照组显效率(44.9%)、有效率(52.9%)、无效率(2.2%)差异无统计学意义;治疗后,2组的LVEF均较治疗前增高,LVEDD、血压均降低,差异有统计学意义;而2组间比较差异均无统计学意义。结论 依那普利和坎地沙坦在治疗高原地区藏族慢性收缩性心力衰竭的效果方面无明显差异。

关键词: 高原, 藏族人群, 坎地沙坦, 慢性收缩性心力衰竭

Abstract: Objective The treatment effect of chronic systolic heart failure with Candesartan in plateau Tibetan nationality is discussed in this paper. Method Cases studied consist of 526 individuals with chronic systolic heart failure, which are divided into two groups randomly (i.e., control group with 252 cases and reference group with 274cases). Routine medicine is given to individuals in both groups on the basement of protopathy treatment, such as cardiac, diuretic and vasodilator drugs. Additionally, enalapril is used in reference group, while candesartan in control group. Comparison of the improvement of cardiac function, LVEF, LVEDD and blood pressure between two groups is also conducted after 8 weeks. Results There was no significant difference between treatment and control groups for effective rate (i.e., 45.2% in treatment group and 44.9% in control group, respectively), efficiency rate (i.e., 54.8% in treatment group and 55.1% in control group, respectively) and Inefficiency (i.e., 2.0% in treatment group and 2.2% in control group, respectively). After treatment, LVEF in the two groups are all improved, while LVEDD and blood pressure decreased, and statistical significance are also found. However, the difference between the two groups is not significant. Conclusion No statistical difference was found for the treatment of chronic systolic heart failure in Plateau Tibetan in the 2 groups, and candesartan seems more effective than enalapril.

Key words: plateau, Tibetan, candesartan, chronic systolic heart failure